SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-20-038894
Filing Date
2020-11-24
Accepted
2020-11-23 20:47:19
Documents
55
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0920_180lifesciences.htm 10-Q 333815
2 CERTIFICATION f10q0920ex31-1_180lifesci.htm EX-31.1 11497
3 CERTIFICATION f10q0920ex32-1_180lifesci.htm EX-32.1 4412
  Complete submission text file 0001213900-20-038894.txt   2778643

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE atnf-20200930.xml EX-101.INS 362388
5 XBRL SCHEMA FILE atnf-20200930.xsd EX-101.SCH 47281
6 XBRL CALCULATION FILE atnf-20200930_cal.xml EX-101.CAL 42160
7 XBRL DEFINITION FILE atnf-20200930_def.xml EX-101.DEF 159123
8 XBRL LABEL FILE atnf-20200930_lab.xml EX-101.LAB 254396
9 XBRL PRESENTATION FILE atnf-20200930_pre.xml EX-101.PRE 233042
Mailing Address 150 WEST 56TH STREET SUITE 5901 NEW YORK NY 10019
Business Address 150 WEST 56TH STREET SUITE 5901 NEW YORK NY 10019 212-319-5555
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

IRS No.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38105 | Film No.: 201339604
SIC: 2834 Pharmaceutical Preparations